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Abstract
Dendritic cell tumors are extremely rare neoplasms arising from antigen-presenting cells of the immune system.
We report a case of a 69-year-old man with an unremarkable medical history who presented with a 2-months
history of a gradually enlarging painless, firm, mobile, 2 × 2-cm swelling at the caudal pole of the left parotid
gland without systemic symptoms. Histologically, the tumor consisted of a spindle cell proliferation in an
intraparotideal lymph node. Based on the histopathologic, immunohistochemical and electron microscopic
findings, a dendritic cell tumor, not otherwise specified (NOS) in an intraparotideal lymph node was diagnosed.
The patient underwent complete tumor resection, and is currently free of disease, 2 years after surgery. These
extremely rare tumors must be distinguished from other more common tumors in the salivary glands. Awareness
that dendritic cell tumors may occur in this localization, careful histologic evaluation and ancillary
immunohistochemical and electron microscopical analyses should allow for recognition of this entity.
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Background
Dendritic cell sarcomas (DCS) are exceedingly rare enti-
ties, arising from antigen-presenting cells of the immune
system. DCS are subclassified into the better character-
ized follicular (FDCS) [1] and interdigitating (IDCS) [2]
dendritic cell sarcomas and other rare and less well clas-
sifiable dendritic cell tumors like fibroblastic reticular
cell tumors, indeterminate dendritic cell tumors and
dendritic cell tumors, not otherwise specified (DCT,
NOS) [2]. DCS was first described in 1986 by Monda et
al. [3]. Since then, nearly 300 cases, most of them
FDCS, have been described in the literature. Although
most DCS evolve in cervical, mediastinal, axillary and
inguinal lymph nodes, also extranodal manifestations
have been described [4]. The clinical behaviour of DCS
is similar to that of low-grade soft tissue sarcoma, with
an approximately 30% overall risk for developing local
recurrences and metastases [5]. Because of the rareness
of the disease a standardized treatment is lacking.
We herein report a case of a dendritic cell tumor,
NOS of an intraparotideal lymph node, emphasizing the
important role of ancillary immunohistochemical and
molecular studies in establishing this extraordinarily
rare diagnosis.
Case report
A 69-year-old man presented with a 2-months history of
a gradually enlarging painless, firm, mobile, 2 × 2 × 2
cm swelling at the caudal pole of the left parotid gland
without systemic symptoms. His medical history was
unremarkable.
Magnet resonance imaging (MRI) showed a 2 × 2 × 2
cm mass with hyperintense signal on T2-weighted
images and hypointense signal on T1-weighted
sequences and a contrast enhancement which bordered
directly to the lateral part of left sternocleidomastoid
muscle and displaced the external jugular vein dorsally.
Cranially there was no clear demarcation to the left par-
otid gland (Figure 1). The patient underwent surgical
excision of the swelling by a partial left parotidectomy
with preservation of the facial nerve. Because of insecure
R0-status a follow-up resection with extended partial
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(levels II and III) was conducted. A primary tumor of
the upper aerodigestive tract was excluded by panendo-
scopy. Subsequent total body positron emission tomo-
graphy with 18-F-fluorodesoxyglucose and computed
tomography scan 6 months after surgery were unre-
markable. The patient is currently disease free, 2 years
after surgery.
Material and methods
The specimen was fixed in 10% buffered formalin, paraf-
fin-embedded, and histologic sections were obtained.
Sections were routinely stained with hematoxylin and
eosin. Immunohistochemical staining was performed on
formalin-fixed, paraffin-embedded tissue sections on an
automated immunostainer (Ventana Medical Systems
©,
Tucson AZ) following the manufacturer’s protocols. The
monoclonal antibodies used are listed in Table 1.
For electron microscopical (EM) evaluation, small
pieces of tissue were dissected out of the paraffin bloc,
rehydrated stepwise and postfixed in 1% OsO4 in 0.1
M cacodylate buffer (pH 7.4) and then again dehy-
drated in an ethanol series (50, 70, 96, 100%). The 70%
ethanol was saturated with uranyl acetate for contrast
enhancement. Dehydration was completed in propylene
oxide. The specimens were embedded in Araldite
(Serva
©, Heidelberg, Germany). Ultrathin sections were
produced on a FCR Reichert Ultracut ultramicrotome
(Leica
©, Bensheim, Germany), mounted on pioloform-
coated copper grids, contrasted with lead citrate and
analyzed and documented with an EM10A electron
microscope (Carl Zeiss
©, Oberkochen, Germany). The
pictures were digitized and processed with Adobe
Photoshop.
Figure 1 Axial MR image. (T2-weighted) of a 2 × 2 cm mass with
hyperintense signal (arrow) directly bordering the lateral part of left
sternocleidomastoid muscle (asterisk) and displacing the extern
jugular vein (arrow head) dorsally. Cranially there was no clear
demarcation to the left parotid gland.
Table 1 List of antibodies and staining results.
Antibody Company Dilution Tumor cells
Vimentin DAKO 1:1000 positive
HLA-DR DAKO 1:200 part.positive
Fascin Abcam 1:100 positive
Langerin eBioscience 1:50 negative
Lysozym DAKO 1:400 negative
S100 DAKO 1:5000 negative
AE1/3 DAKO 1:100 negative
HMB45 DAKO 1:50 negative
MITF Zytomed 1:100 negative
PMZ Zytomed 1:50 negative
LCA DAKO 1:500 negative
Calponin DAKO 1:200 negative
Caldesmon DAKO 1:50 negative
Clusterin Menarini 1:30 negative
EMA DAKO 1:100 negative
SMA DAKO 1:500 negative
CK5/6 DAKO 1:100 negative
CK8/18 Zytomed 1:100 negative
OSCAR Zytomed 1:200 negative
Synaptophysin DCS 1:200 negative
Chromogranin DAKO 1:500 negative
Factor XIIIa DCS 1:100 negative
CD1a DAKO 1:50 negative
CD3 Santa Cruz 1:200 negative
CD4 Zytomed 1:200 negative
CD20 DAKO 1:500 negative
CD21 Zytomed 1:50 negative
CD23 Novocastra 1:30 negative
CD30 DAKO 1:50 negative
CD31 DAKO 1:100 negative
CD34 DAKO 1:50 negative
CD35 Novocastra 1:50 negative
CD56 Cell Marque 1:100 negative
CD68 (PG-M1) DAKO 1:200 negative
CD117 DAKO 1:200 negative
CD123 BD Pharmingen 1:50 negative
Mib1 DAKO 1:200 40-50%
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Gross and histological findings
The specimen consisted of parotid gland tissue contain-
ing a single firm, nodule 2.3 cm in diameter. The cut
surface was soft and homogeneous light-grey. Micro-
scopic examination revealed a spindle cell neoplasia in
an intraparotideal lymph node. Tumor cells featured
moderate nuclear pleomorphism, bulked chromatin and
a clearly perceptible nucleolus (Figure 2A, B). Further-
more an elevated mitotic rate (up to 27 mitoses per 10
high power fields) was found.
Immunohistochemical Findings
To further characterize the histogenesis of this tumor,
immunohistochemical stainings were performed. The
tumor cells were positive for vimentin, fascin and HLA-
Figure 2 Morphology and immunohistochemical stainings:( A) H&E (original magnification 100×) and (B) H&E (original magnification 400×)
show a spindle cell proliferation in an intraparotideal lymph node with moderate cellular pleomorphy (C) Vimentin (original magnification 400×)
and (D)HLA-DR (original magnification 400×) were strongly expressed by the tumor cells. (E) Clusterin (original magnification 400×) and (F) S100
protein (original magnification 400×) were negative in the tumor cells. (G)CD20 showed only very few reactive small B-cells (original
magnification 400×) and (H) CD3 some reactive T-lymphocytes (original magnification 400×). Virtual Slides: http://diagnosticpathology.slidepath.
com/dih/webViewer.php?snapshotId=1316777507, http://diagnosticpathology.slidepath.com/dih/webViewer.php?snapshotId=1316777681, http://
diagnosticpathology.slidepath.com/dih/webViewer.php?snapshotId=1316777716, http://diagnosticpathology.slidepath.com/dih/webViewer.php?
snapshotId=1316777754, http://diagnosticpathology.slidepath.com/dih/webViewer.php?snapshotId=1316777781
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negative for all epithelial, melanocytic, lymphoid, histo-
cytic and follicular dendritic cell markers used. The pro-
liferation, as assessed by Mib1 index was 40-50%. The
results of the immuohistochemical stainings are shown
in table 1.
Electron Microscopic Findings
The electron microscopical aspect of the tissue was
characterized by cells which were devoid of characteris-
tic structures as desmosomes or Birbeck granules. There
was a certain heterogeneity of nuclei concerning their
amount of heterochromatin. However, the cytoplasm of
the cells (size, content of mitochondria or endoplasmatic
reticulum) was less well differentiated (Figure 3A). The
most prominent finding was the large number of slender
long-spacing collagen fibers dividing the tissue in many
compartments (Figure 3A). Fibrous long-spacing col-
lagen the period length of which was in the order of
200 nm in this case (Figure 3B), is not described in the
literature to be specific for any disease, but has been
found in a variety of normal and pathological tissues.
Therefore, it cannot be used as a pathognomonic mar-
ker here.
In summary, the morphological and immunophenoty-
pic features were consistent with a dendritic cell tumor,
not otherwise specified (NOS) originating in an intra-
parotideal lymph node. A differentiation towards a
follicular or interdigitating dendritic cell sarcoma could
not be demonstrated.
Conclusions
Dendritic cell sarcomas (DCS) are rare neoplasms aris-
ing from antigen-presenting cells of the immune system
[2]. DCS are being recognized with an increasing fre-
quency. These tumors can occur, where dendritic cells
are located. One of the most common manifestation
sites are the head and neck region. Under-recognition of
this entity may contribute to its rarity. The WHO sub-
classifies DCS into five groups [2]: Langerhans cell his-
tiocytosis, Langerhans cell sarcoma, interdigitating
dendritic cell sarcoma (IDCS), follicular dendritic cell
sarcoma (FDCS) and other rare and less well classifiable
dendritic cell tumors like fibroblastic reticular cell
tumors, indeterminate dendritic cell tumors and dendri-
tic cell tumors, not otherwise specified (DCT, NOS) [2].
FDCS is the most common subtype followed by IDCS.
The clinical course of this neoplasia is similar to that
of soft tissue sarcomas [3,6]. Since only 306 cases of
DCS have been reported worldwide (table 2), there is no
general consensus on the treatment of this rare disease.
Surgery has remained the gold standard in localized dis-
ease, but a recurrence rate up to 50% has been reported
[5]. Alternatively some DCS have also been treated addi-
tionally by radiotherapy and or chemotherapy [7]. For
our patient we chose the option of surgical therapy and
Figure 3 Electron microscopy (EM): Most prominent feature was the large number of slender long-spacing collagen fibers dividing the tissue
in many compartments (A). Fibrous long-spacing collagen the period length of which was in the order of 200 nm in this case (B), is not
described in the literature to be specific for any disease, but has been found in a variety of normal and pathological tissues. Well-formed
desmosomes or Birbeck granules were not found in this case.
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now.
For establishing the diagnosis a large number of
immunohistochemical stainings and ultrastructural ana-
lyses has been performed. Other rare differential diagno-
sis of salivary glands, like lipomatous pleomorphic
adenoma [8] or sebaceous adenoma [9], were excluded.
Despite this extensive work-up a definite assignation to
an established entity of dendritic cell tumors could not
be achieved. Therefore a diagnosis of dendritic cell
tumor, NOS was made.
In summary, we report on the clinical, pathologic, and
immunohistochemical features of a dendritic cell tumor,
NOS in an intraparotideal lymph node. Metastatic dis-
ease was ruled out by PET- and CT imaging. Recogni-
tion of this extremely rare tumor, and its distinction
from more common malignant tumors of lymph nodes
and salivary glands largely depends on judicious applica-
tion of immunohistochemical and ultrastructural techni-
ques. The precise histogenesis of these extraordinarily
rare tumors remains to be established.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Acknowledgements
This publication was funded by the German Research Foundation (DFG) and
the University of Wuerzburg in the funding programme Open Access
Publishing.
Author details
1Department of Otolaryngology, Head and Neck Surgery, University of
Tübingen, Elfriede-Aulhorn-Straße 5, D-72076 Tübingen, Germany.
2Department of Otolaryngology, Head and Neck Surgery, University of Halle-
Wittenberg, Magdeburger Straße 12, D-06112 Halle (Saale), Germany.
3Department of Diagnostic and Interventional Radiology, University of
Tübingen, Hoppe-Seyler-Straße 3, D-72076 Tübingen, Germany.
4Institute of
Pathology and Comprehensive Cancer Center (CCC), University of Tübingen,
Liebermeisterstraße 8, D-72076 Tübingen, Germany.
5University of Würzburg,
Department of Otolaryngology, Head and Neck Surgery, Josef-Schneider-
Strasse 11, 97080 Würzburg, Germany.
Authors’ contributions
SPS SKP and RS designed the study, collected the clinical data and drafted
the manuscript. HW carried out the electron microscopic analyses. FF and
PA performed the histopathologic and immunohistochemical analyses and
helped to draft the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 3 August 2011 Accepted: 30 September 2011
Published: 30 September 2011
References
1. Chan JKC: Follicular dendritic cell sarcoma. WHO Classification of tumors of
haematopoietic and lymphoid tissue WHO; 2008, 363-364.
2. Weiss LMG, T M, Chan JKC: Interdigitating dendritic cell sarcoma. 2008.
3. Monda L, Warnke R, Rosai J: A primary lymph node malignancy with
features suggestive of dendritic reticulum cell differentiation. A report of
4 cases. Am J Pathol 1986, 122(3):562-572.
4. Li L, Shi YH, Guo ZJ, Qiu T, Guo L, Yang HY, Zhang X, Zhao XM, Su Q:
Clinicopathological features and prognosis assessment of extranodal
follicular dendritic cell sarcoma. World J Gastroenterol 2010,
16(20):2504-2519.
5. De Pas T, Spitaleri G, Pruneri G, Curigliano G, Noberasco C, Luini A,
Andreoni B, Testori A, de Braud F: Dendritic cell sarcoma: an analytic
overview of the literature and presentation of original five cases. Crit Rev
Oncol Hematol 2008, 65(1):1-7.
6. Perez-Ordonez B, Erlandson RA, Rosai J: Follicular dendritic cell tumor:
report of 13 additional cases of a distinctive entity. Am J Surg Pathol
1996, 20(8):944-955.
7. Efune G, Sumer BD, Sarode VR, Wang HY, Myers LL: Interdigitating
dendritic cell sarcoma of the parotid gland: case report and literature
review. Am J Otolaryngol 2009, 30(4):264-268.
8. Kondo T: A case of lipomatous pleomorphic adenoma in the parotid
gland: a case report. Diagn Pathol 2009, 4:16.
9. Bersch C, Back W: Primary sebacous adenoma of the salivary glands - a
rare differential diagnosis: report of a case. Diagn Pathol 2007, 2(Suppl
1):16.
10. Aboujaoude R, Alvarez JR, Alvarez M, Al-Khan A: Follicular dendritic cell
sarcoma in pregnancy: case report and review of the literature. Am J
Perinatol 2006, 23(8):459-461.
11. Amiri-Kordestani L, Priebat D, Chia SH: Follicular dendritic cell sarcoma of
the neck: case report and review of current diagnostic and
management strategies. Ear Nose Throat J 2010, 89(7):E14-17.
12. Androulaki A, Liapis G, Alexandrou P, Lazaris AC: Retroperitoneal follicular
dendritic cell sarcoma. Int J Hematol 2006, 84(1):2.
13. Aydin E, Ozluoglu LN, Demirhan B, Arikan U: Follicular dendritic cell
sarcoma of the tonsil: case report. Eur Arch Otorhinolaryngol 2006,
263(12):1155-1157.
14. Azim HA, Elsedewy E, Azim HA Jr: Imatinib in the treatment of follicular
dendritic sarcoma: a case report and review of literature. Onkologie 2007,
30(7):381-384.
15. Boldin I, Brix-Grunwald G, Scarpatetti MM, Beham-Schmid C, Klein A:
Interdigitating dendritic cell sarcoma of the eyelid with a rapidly fatal
course. Arch Ophthalmol 2008, 126(5):738-740.
16. Cano JR, Cerezo F, Gonzalez A, Marchal T, Salvatierra A: [Follicular dendritic
cell tumour in the anterior mediastinum]. Cir Esp 2009, 85(4):254-256.
17. Chera BS, Orlando C, Villaret DB, Mendenhall WM: Follicular dendritic cell
sarcoma of the head and neck: case report and literature review.
Laryngoscope 2008, 118(9):1607-1612.
18. Choi JW, Lee JH, Kim A, Kim CH, Chae YS, Kim I: Follicular dendritic cell
sarcoma arising in the dura mater of the spine. Arch Pathol Lab Med
2006, 130(11):1718-1721.
19. Choi BS, Baek JH, Shin YM, Kim JH, Kim HW, Lee SJ, Cha HJ: Follicular
dendritic cell sarcoma: a case report and review of the literature. Cancer
Res Treat 2010, 42(2):121-124.
Table 2 Overview of dendritic cell sarcoma case reports.
FDCS IDCS
1986 - 4/2007 *
Nodal 77 33 110
Extranodal 52 22 74
5/2007 - 08/2011 [5,7,10-86]
Nodal 68 14 82
Extranodal 33 7 40
230 76 306
FDCS, follicular dendritic cell sarcoma; IDCS, interdigitating cell sarcoma. *
Modified from [5]. A total of 145 nodal FDCS cases, 85 extranodal FDCS cases,
47 nodal IDCS cases and 29 extranodal cases have been reported until 08/
2011. 2 cases FDCS and 2 cases of IDCS occured in the parotid gland.
Schraven et al. Diagnostic Pathology 2011, 6:94
http://www.diagnosticpathology.org/content/6/1/94
Page 5 of 720. Clement P, Saint-Blancard P, Minvielle F, Le Page P, Kossowski M: Follicular
dendritic cell sarcoma of the tonsil: a case report. Am J Otolaryngol 2006,
27(3):207-210.
21. Cossu A, Deiana A, Lissia A, Dedola MF, Cocco L, Palmieri G, Tanda F:
Synchronous interdigitating dendritic cell sarcoma and B-cell small
lymphocytic lymphoma in a lymph node. Arch Pathol Lab Med 2006,
130(4):544-547.
22. Cyriac S, Praveenkumar D, Majhi U, Sagar TG: Follicular dendritic cell
sarcoma of the neck with an aggressive and fatal course. J Cancer Res
Ther 2010, 6(1):114-116.
23. Denning KL, Olson PR, Maley RH Jr, Flati VR, Myers JL, Silverman JF: Primary
pulmonary follicular dendritic cell neoplasm: a case report and review of
the literature. Arch Pathol Lab Med 2009, 133(4):643-647.
24. Diaz de Liano A, Garde C, Artieda C, Yarnoz C, Flores L, Ortiz H: Intra-
abdominal follicular dendritic cell sarcoma. Clin Transl Oncol 2006,
8(11):837-838.
25. Duan GJ, Wu F, Zhu J, Guo DY, Zhang R, Shen LL, Wang SH, Li Q, Xiao HL,
Mou JH, et al: Extranodal follicular dendritic cell sarcoma of the
pharyngeal region: a potential diagnostic pitfall, with literature review.
Am J Clin Pathol 133(1):49-58.
26. Encabo RS, McHugh J, Carrau RL, Kassam A, Heron D: Follicular dendritic
cell sarcoma of the nasopharynx. Am J Otolaryngol 2008, 29(4):262-264.
27. Eun YG, Kim SW, Kwon KH: Follicular dendritic cell sarcoma of the tonsil.
Yonsei Med J 2010, 51(4):602-604.
28. Fan YS, Ng WK, Chan A, Chan GS, Tsang J, Chim CS, Ip P: Fine needle
aspiration cytology in follicular dendritic cell sarcoma: a report of two
cases. Acta Cytol 2007, 51(4):642-647.
29. Fraser CR, Wang W, Gomez M, Zhang T, Mathew S, Furman RR,
Knowles DM, Orazi A, Tam W: Transformation of chronic lymphocytic
leukemia/small lymphocytic lymphoma to interdigitating dendritic cell
sarcoma: evidence for transdifferentiation of the lymphoma clone. Am J
Clin Pathol 2009, 132(6):928-939.
30. Gach JE, Carr RA, Charles-Holmes R: Nodal follicular dendritic cell sarcoma
of the axilla presenting as cellulitis. Br J Dermatol 2006, 154(1):177-178.
31. Gong QX, Fan QH, Zhou ZS, Zhang ZH, Yu MN, Wang Z, Wang C,
Zhang WM: [Inflammatory pseudotumor-like follicular dendritic cell
tumor of spleen]. Zhonghua Bing Li Xue Za Zhi 2008, 37(1):40-44.
32. Gordon MK, Kraus M, van Besien K: Interdigitating dendritic cell tumors in
two patients exposed to topical calcineurin inhibitors. Leuk Lymphoma
2007, 48(4):816-818.
33. Granados R, Aramburu JA, Rodriguez JM, Nieto MA: Cytopathology of a
primary follicular dendritic cell sarcoma of the liver of the inflammatory
pseudotumor-like type. Diagn Cytopathol 2008, 36(1):42-46.
34. Han HS, Lee OJ, Lim SN, An JY, Lee KM, Choe KH, Lee KH, Kim ST:
Extranodal interdigitating dendritic cell sarcoma presenting in the
pleura: a case report. J Korean Med Sci 2011, 26(2):304-307.
35. Hartert M, Strobel P, Dahm M, Nix W, Marx A, Vahl CF: A follicular dendritic
cell sarcoma of the mediastinum with immature T cells and association
with myasthenia gravis. Am J Surg Pathol 2010, 34(5):742-745.
36. Hollingsworth J, Cooper WA, Nicoll KD, Wills EJ, Thiruvilangam V, Lee CS,
Scolyer RA: Follicular dendritic cell sarcoma of the lung: a report of two
cases highlighting its pathological features and diagnostic pitfalls.
Pathology 2011, 43(1):67-70.
37. Ishihara S, Honda Y, Asato T, Nonaka M, Nakagawa S, Hirashima K,
Hayashi N, Baba H, Iyama K: Interdigitating dendritic cell sarcoma of the
ileum recurred in multiple lymph nodes and duodenum three years
after operation without chemotherapy. Pathol Res Pract 2010,
206(7):514-518.
38. Jiang L, Admirand JH, Moran C, Ford RJ, Bueso-Ramos CE: Mediastinal
follicular dendritic cell sarcoma involving bone marrow: a case report
and review of the literature. Ann Diagn Pathol 2006, 10(6):357-362.
39. Jo S, Babb MJ, Hilsinger RL Jr: Interdigitating dendritic cell sarcoma of
cervical lymph nodes. Arch Otolaryngol Head Neck Surg 2006,
132(11):1257-1259.
40. Kanaan H, Al-Maghrabi J, Linjawi A, Al-Abbassi A, Dandan A, Haider AR:
Interdigitating dendritic cell sarcoma of the duodenum with rapidly fatal
course: a case report and review of the literature. Arch Pathol Lab Med
2006, 130(2):205-208.
41. Kapucuoglu N, Percinel S, Ventura T, Lang R, Al-Daraji W, Eusebi V:
Dendritic cell sarcomas/tumours of the breast: report of two cases.
Virchows Arch 2009, 454(3):333-339.
42. Karaman E, Saritzali G, Kilic E, Korkut N, Enver O: Follicular dendritic cell
sarcoma of the parotid gland recurring 6 times within 12 years. J
Craniofac Surg 2009, 20(6):2171-2172.
43. Khalid S, Yaqoob N, Pervez S: Follicular dendritic cell sarcoma of lymph
node–a rare entity. J Pak Med Assoc 2006, 56(3):137-139.
44. Kim SY, Kang JH, Chun SH, Chang MH, Kim YS, Lee SN, Kim MS, Kang CS:
Interdigitating dendritic cell sarcoma of the tonsil. Asia Pac J Clin Oncol
2010, 6(3):144-148.
45. Kim H, Park CM, Jeon YK, Yoo IR, Song SW, Goo JM, Lee HJ: Computed
Tomography and 18F-fluoro-2-deoxyglucose Positron Emission
Tomography Findings of Primary Pulmonary Follicular Dendritic Cell
Sarcoma: Case Report and a Literature Review. J Thorac Imaging 2011.
46. Kovacs RB, Sattar HA, Krausz T, Kas J, Berta M, Sapi Z: Primary follicular
dendritic cell sarcoma of the lung. Histopathology 2006, 49(4):431-433.
47. Kure K, Khader SN, Suhrland MJ, Ratech H, Grossberg R, Oktay MH: Fine
needle aspiration of follicular dendritic cell sarcoma in an HIV-positive
man: a case report. Acta Cytol 2010, 54(5):707-711.
48. Leipsic JA, McAdams HP, Sporn TA: Follicular dendritic cell sarcoma of the
mediastinum. AJR Am J Roentgenol 2007, 188(6):W554-556.
49. Li J, Duan MH, Han B, Zhang W, Zhou DB, Zhao YQ, Shen T: [Dendritic cell
sarcoma: 4 cases report with literature review]. Zhonghua Xue Ye Xue Za
Zhi 2008, 29(4):263-266.
50. Liu X, Deng Y, Zhang X, Mukherjee R, Huang W, Zhang G, Wang H, Li X:
Interdigitating dendritic cell sarcoma following adult liver
transplantation: case report and literature review. Pathol Oncol Res 2011,
17(2):397-402.
51. Long-Hua Q, Qin X, Ya-Jia G, Jian W, Xiao-Yuan F: Imaging findings of
follicular dendritic cell sarcoma: report of four cases. Korean J Radiol
2011, 12(1):122-128.
52. Low SE, Menasce LP, Manson CM: Follicular dendritic cell sarcoma: a rare
tumor presenting as an abdominal mass. Int J Surg Pathol 2007,
15(3):315-317.
53. Ludwig A: [Extranodal follicular dendritic cell sarcoma of the tonsils]. Hno
2006, 54(9):701-704.
54. Majhi U, Shirley S, Murhekar K: Follicular dendritic cell sarcoma of oral
cavity: report of 2 cases. Indian J Pathol Microbiol 2007, 50(3):545-547.
55. Martins PN, Reddy S, Martins AB, Facciuto M: Follicular dendritic cell
sarcoma of the liver: unusual presentation of a rare tumor and literature
review. Hepatobiliary Pancreat Dis Int 2011, 10(4):443-445.
56. Miyagi T, Nagasaki A, Shinzato O, Ohshima K, Takasu N: [Interdigitating
dendritic cell sarcoma/tumor–a case report]. Gan To Kagaku Ryoho 2007,
34(3):469-471.
57. Padilla-Rodriguez AL, Bembassat M, Lazaro M, Ortiz-Hidalgo C: Intra-
abdominal follicular dendritic cell sarcoma with marked pleomorphic
features and aberrant expression of neuroendocrine markers: report of a
case with immunohistochemical analysis. Appl Immunohistochem Mol
Morphol 2007, 15(3):346-352.
58. Pailoor J, Iyengar KR, Chan KS, Sumithra S: Follicular dendritic cell sarcoma
of inguinal lymph node–a case report. Malays J Pathol 2008, 30(2):115-119.
59. Pisani F, Marino M, Sentinelli S, Petti MC: Follicular dendritic cell sarcoma
of the neck: report of a case treated by surgical excision and COP plus
(PEG)-liposomal doxorubicin. J Exp Clin Cancer Res 2008, 27:33.
60. Pizzi M, Ludwig K, Palazzolo G, Busatto G, Rettore C, Altavilla G: Cervical
follicular dendritic cell sarcoma: a case report and review of the
literature. Int J Immunopathol Pharmacol 2011, 24(2):539-544.
61. Romero-Guadarrama MB, Reyes-Posada O, Hernandez-Gonzalez MM, Duran-
Padilla MA: Follicular dendritic cell sarcoma/tumor: 2 cases of a rare
tumor of difficult clinical and pathological diagnosis. Ann Diagn Pathol
2009, 13(4):257-262.
62. Sander B, Middel P, Gunawan B, Schulten HJ, Baum F, Golas MM, Schulze F,
Grabbe E, Parwaresch R, Fuzesi L: Follicular dendritic cell sarcoma of the
spleen. Hum Pathol 2007, 38(4):668-672.
63. Shen SC, Wu CC, Ng KF, Wu RC, Chen HM, Chen TC: Follicular dendritic
cell sarcoma mimicking giant cell carcinoma of the pancreas. Pathol Int
2006, 56(8):466-470.
64. Shen DP, Ni XZ, Yin XL, Wu ZY: Clinical and pathological features of
follicular dendritic cell sarcoma of appendix: a case report. Chin Med J
(Engl) 2009, 122(13):1595-1597.
65. Silver AL, Faquin WC, Caruso PA, Deschler DG: Follicular dendritic cell
sarcoma presenting in the submandibular region in an 11 year-old.
Laryngoscope 2011, 120(Suppl 4):S183.
Schraven et al. Diagnostic Pathology 2011, 6:94
http://www.diagnosticpathology.org/content/6/1/94
Page 6 of 766. Soriano AO, Thompson MA, Admirand JH, Fayad LE, Rodriguez AM,
Romaguera JE, Hagemeister FB, Pro B: Follicular dendritic cell sarcoma: a
report of 14 cases and a review of the literature. Am J Hematol 2007,
82(8):725-728.
67. Suhail Z, Musani MA, Afaq S, Zafar A, Ahmed Ashrafi SK: Follicular dendritic
cell sarcoma of tonsil. J Coll Physicians Surg Pak 2010, 20(1):55-56.
68. Suzuki N, Katsusihma H, Takeuchi K, Nakamura S, Ishizawa K, Ishii S,
Moriya T, DeCoteau JF, Miura I, Ichinohasama R: Cytogenetic abnormality
46, XX, add(21)(q11.2) in a patient with follicular dendritic cell sarcoma.
Cancer Genet Cytogenet 2008, 186(1):54-57.
69. Tokyol C, Yilmaz MD, Ekici O, Aktepe F: Follicular dendritic cell sarcoma: a
case report. Acta Cytol 2008, 52(2):235-239.
70. Tu XY, Sheng WQ, Lu HF, Wang J: [Clinicopathologic study of
intraabdominal extranodal follicular dendritic cell sarcoma]. Zhonghua
Bing Li Xue Za Zhi 2007, 36(10):660-665.
71. Vaideeswar P, George SM, Kane SV, Chaturvedi RA, Pandit SP: Extranodal
follicular dendritic cell sarcoma of the tonsil - case report of an
epithelioid cell variant with osteoclastic giant cells. Pathol Res Pract 2009,
205(2):149-153.
72. Vives S, Fernandez MT, Lopez de Castro PE, Ribera JM: [Interdigitating
dendritic cell sarcoma with localization to the lung]. Med Clin (Barc) 2006,
126(14):559.
73. Voigt LP, Hmidi A, Pastores SM, Maki RG, Carlson DL, Bains MS, Halpern NA:
Management dilemmas due to a paratracheal follicular dendritic cell
tumor. Ann Thorac Surg 2006, 82(5):1898-1900.
74. Wang LF, Wang RF, Wang ZC, Han W, Mei HL, Liu M: [Follicular dendritic
cell sarcoma of stomach: report of a case]. Zhonghua Bing Li Xue Za Zhi
2008, 37(3):210-211.
75. Wang XI, Zhang S, Thomas JO, Adegboyega PA: Cytomorphology,
ultrastructural, and cytogenetic findings in follicular dendritic cell
sarcoma: a case report. Acta Cytol 2010, 54(5 Suppl):759-763.
76. Wang H, Su Z, Hu Z, Wen J, Liu B: Follicular dendritic cell sarcoma: a
report of six cases and a review of the Chinese literature. Diagn Pathol
2010, 5:67.
77. Wang Q, An L, Cui N, Sha J, Zhu D: [Follicular dendritic cell sarcoma: a
case report and review of literature]. Lin Chung Er Bi Yan Hou Tou Jing
Wai Ke Za Zhi 2011, 25(3):100-102.
78. Wu Q, Liu C, Lei L, Yan X, Wang B, Liu X, Yv L, Lv Y: Interdigitating
dendritic cell sarcoma involving bone marrow in a liver transplant
recipient. Transplant Proc 2010, 42(5):1963-1966.
79. Yakushijin Y, Shikata H, Kito K, Ohshima K, Kojima K, Hato T, Hasegawa H,
Yasukawa M: Follicular dendritic cell tumor as an unknown primary
tumor. Int J Clin Oncol 2007, 12(1):56-58.
80. Yamada Y, Haga H, Hernandez M, Kubota KC, Orii F, Nagashima K,
Matsuno Y: Follicular dendritic cell sarcoma of small intestine with
aberrant T-cell marker expression. Pathol Int 2009, 59(11):809-812.
81. Yang GC, Wang J, Yee HT: Interwoven dendritic processes of follicular
dendritic cell sarcoma demonstrated on ultrafast papanicolaou-stained
smears: a case report. Acta Cytol 2006, 50(5):534-538.
82. Yu L, Yang SJ: Primary Follicular Dendritic Cell Sarcoma of the Thyroid
Gland Coexisting With Hashimoto’s Thyroiditis. Int J Surg Pathol 2009.
83. Zhang ZX, Cheng J, Shi QL, Ma J, Zhou XJ, Zhou HB, Ma HH: [Follicular
dendritic cell sarcoma: a clinicopathologic study of 8 cases]. Zhonghua
Bing Li Xue Za Zhi 2008, 37(6):395-399.
84. Zhong GP, Sun WY, Gan MF, Yuan MC: [Follicular dendritic cell sarcoma: a
clinicopathologic study of five cases]. Zhonghua Bing Li Xue Za Zhi 2006,
35(10):612-615.
85. Zhou ZY, Sun RC, Yang SD, Liang JB, Rui J, Pan MH: Interdigitating
dendritic cell tumor of the lymph node in the right submaxillary region:
a case report and review of the literature. Int J Surg Pathol 2011,
19(1):88-92.
86. Zivkovic V, Basic M, Gligorijevic J, Pavlovic V, Lazarevic V, Petrovic A:
Follicular dendritic cell sarcoma in the lymph nodes of the neck. Bratisl
Lek Listy 2007, 108(8):368-370.
doi:10.1186/1746-1596-6-94
Cite this article as: Schraven et al.: Dendritic cell tumor in a salivary
gland lymph node: a rare differential diagnosis of salivary gland
neoplasms. Diagnostic Pathology 2011 6:94.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Schraven et al. Diagnostic Pathology 2011, 6:94
http://www.diagnosticpathology.org/content/6/1/94
Page 7 of 7